Belite Bio BLTE
NASDAQ BLTE
$162.98 -6.84 (-4.03%)
At close: Oct 1, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Net Equity Issued and Repurchased (2020 - 2025)

Updated

Belite Bio's Net Equity Issued and Repurchased came in at $102.64 million for Q4 2025, up 257.0% from $28.75 million a year earlier.

Analysis

Belite Bio (BLTE) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

For FY2025, Belite Bio's Net Equity Issued and Repurchased was $102.99 million, up 164.4% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 312.7% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $38.96 million in FY2024 (+79.9%), $21.65 million in FY2023 (-43.0%), $37.99 million in FY2022 and $232,000 in FY2021 (+169.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Belite Bio 6.68 Bn 6.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 102.64 Mn
Dec 31, 2024 28.75 Mn
Dec 31, 2020 86,000.00
API Access

Belite Bio Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BLTE&period=max&api_key=YOUR_API_KEY